trelleborg0412Trelleborg Sealing Solutions Silcotech AG is investing 10 million Swiss francs in the manufacture of life science products in Stein am Rhein. Following the acquisition of the liquid silicone processing specialist by Trelleborg Sealing Solutions, Silcotech's production capacity for cleanroom products will be tripled. This prepares the location for the global sales activities of the specialist in sealing solutions.

In addition, the company is responding to both increased demand for on-going products and increasing demand for new medical and pharmaceutical products.

"With the expanded manufacturing capacity, we are creating the conditions for increased orders that we will receive through the global sales activities of Trelleborg Sealing Solutions," emphasizes Matthias Jakob, Managing Director of Silcotech. He sees the company significantly strengthened in the global market development following last year's acquisition by Trelleborg Sealing Solutions. "After all, Trelleborg itself is a pioneer of the first days in the processing of silicone and can win customers and orders for our production site worldwide," says Jakob. However, the capacity expansion is also necessary because an asthma medication from a large German pharmaceutical company is conquering more and more markets. "We recently started production of four silicone gaskets for a seven-day production," says Jakob, describing the need for growth.

The now planned investment of ten million Swiss francs will triple the capacity of the clean room production and increase the production capacity of the site by a total of more than 2013% in 30. The new three-story building complex will house an ISO 7 clean room (10.000 particles <0,1 µm) and a ISO 8 clean room (100.000 particles <0,1 µm) according to ISO 13485.